Partner Content

Partner Content
Exscientia to discuss role of AI in small molecule drug disc...
SMi reports: Andrew Hopkins, Chief Executive at Exscientia to discuss the role of Artificial Intelligence in small molecule drug discovery at SMi’s Drug Discovery conference in March 2018